Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Australia is handicapped in the delivery of cell therapies, says Alan Trounson
By Christine Filippis / March 21, 2019
THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer...
Read More
Safer cells for immunotherapy
By Christine Filippis / February 13, 2019
Cartherics Pty Ltd teams up with Canada's panCELLa Inc to bring the power of safe cell therapy to a greater...
Read More
Eradicate Cancer 2020 – Next frontiers in immunotherapy
By Christine Filippis / January 29, 2019
Melbourne Convention and Exhibition Centre, 25-27 March 2020 "Success Breeds Success" The field of immunotherapy against cancers is making unprecedented...
Read More
